VFA
SGMO

Virtus Fund Advisers’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Virtus Fund Advisers’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$354K Buy
+21,591
New +$321K ﹤0.01% 395
2015
Q2 		– Sell
-57,569
Closed -$903K – 885
2015
Q1 		$903K Sell
57,569
-5,345
-8% -$82.7K 0.01% 359
2014
Q4 		$957K Buy
62,914
+304
+0.5% +$3.69K 0.01% 375
2014
Q3 		$675K Sell
62,610
-5,360
-8% -$70K 0.01% 418
2014
Q2 		$1.04M Buy
+67,970
New +$978K 0.01% 448

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virtus Fund Advisers's SGMO Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q4 2017: 21,591 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #395 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in SGMO as recently as Q1 2015.

Virtus Fund Advisers first reported a position in SGMO in Q2 2014 and has held it in 5 quarters since. The position peaked at $1.04M in Q2 2014. 170 funds tracked by Wall St. Rank hold SGMO as of Q4 2017.

  • Virtus Fund Advisers held 21,591 shares of SANGAMO THERAPEUTICS INC worth $354K as of Q4 2017.
  • SANGAMO THERAPEUTICS INC was a new Virtus Fund Advisers position in Q4 2017.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #395 holding.
  • Virtus Fund Advisers first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and has held it in 5 quarters since.
  • Virtus Fund Advisers's SANGAMO THERAPEUTICS INC position peaked at $1.04M in Q2 2014.
  • 170 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.